Research Article
Serum Adiponectin Level as a Predictor of Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma
Table 2
Hormonal profiles and adenoma diameters of the patients with adrenal incidentaloma.
| | | Patients with AI | | | | Patients with SCS | Patients with NAI | | | Median () | Median () |
| | Adenoma diameter, cm | 3.05 (2.25–3.55) | 1.85 (1.60–3.00) | 0.154 | | Basal cortisol at 08:00 a.m., µg/dL | 16.30 (13.20–24.65) | 17.05 (12.40–21.25) | 0.554 | | Midnight cortisol, µg/dL | 9.15 (7.00–12.25) | 5.10 (3.80–7.80) | 0.004 | | ACTH, pg/mL | 9.25 (8.60–12.00) | 10.70 (8.55–13.00) | 0.612 | | DHEAS, mg/dL | 22.10 (15.00–41.95) | 51.65 (42.00–113.00) | 0.054 | | UFC, µg/24 h | 249 (215–366) | 170 (140–220) | 0.007 |
|
|
AI, adrenal incidentaloma; SCS, subclinical Cushing’s syndrome; NAI, nonfunctional adrenal incidentaloma; ACTH, adrenocorticotropic hormone; DHEAS, dehydroepiandrosterone sulfate; UFC, urinary free cortisol.
|
